DK0637334T3 - Peptider med en GDP-udskiftningsfaktoraktivitet, nukleinsyresekvenser, der koder for disse peptider, fremstilling og anvendelse - Google Patents

Peptider med en GDP-udskiftningsfaktoraktivitet, nukleinsyresekvenser, der koder for disse peptider, fremstilling og anvendelse

Info

Publication number
DK0637334T3
DK0637334T3 DK93911529T DK93911529T DK0637334T3 DK 0637334 T3 DK0637334 T3 DK 0637334T3 DK 93911529 T DK93911529 T DK 93911529T DK 93911529 T DK93911529 T DK 93911529T DK 0637334 T3 DK0637334 T3 DK 0637334T3
Authority
DK
Denmark
Prior art keywords
peptides
gdp
preparation
nucleic acid
acid sequences
Prior art date
Application number
DK93911529T
Other languages
English (en)
Inventor
Fabien Schweighoffer
Bruno Tocque
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK0637334T3 publication Critical patent/DK0637334T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK93911529T 1992-04-21 1993-04-19 Peptider med en GDP-udskiftningsfaktoraktivitet, nukleinsyresekvenser, der koder for disse peptider, fremstilling og anvendelse DK0637334T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9204827A FR2690162B1 (fr) 1992-04-21 1992-04-21 Peptides ayant une activite de facteur d'echange du gdp, sequences d'acides nucleiques codant pour ces peptides, preparation et utilisation.
PCT/FR1993/000382 WO1993021314A1 (fr) 1992-04-21 1993-04-19 Peptides ayant une activite de facteur d'echange du gdp, sequences d'acides nucleiques codant pour ces peptides, preparation et utilisation

Publications (1)

Publication Number Publication Date
DK0637334T3 true DK0637334T3 (da) 2007-10-08

Family

ID=9429043

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93911529T DK0637334T3 (da) 1992-04-21 1993-04-19 Peptider med en GDP-udskiftningsfaktoraktivitet, nukleinsyresekvenser, der koder for disse peptider, fremstilling og anvendelse

Country Status (11)

Country Link
US (1) US5656595A (da)
EP (1) EP0637334B1 (da)
JP (1) JP3681384B2 (da)
AT (1) ATE364079T1 (da)
CA (1) CA2131166A1 (da)
DE (1) DE69334146T2 (da)
DK (1) DK0637334T3 (da)
ES (1) ES2287927T3 (da)
FR (1) FR2690162B1 (da)
PT (1) PT637334E (da)
WO (1) WO1993021314A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840683A (en) * 1995-09-21 1998-11-24 Innapharma, Inc. Peptides inhibiting the oncogenic action of p21 ras
US5910478A (en) * 1995-09-21 1999-06-08 Innapharma, Inc. Peptidomimetics inhibiting the oncogenic action of p21 ras
US6340575B1 (en) * 1997-06-17 2002-01-22 Onyx Pharmaceuticals, Inc. Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activity
IT1293491B1 (it) * 1997-07-08 1999-03-01 Dompe Spa Mutanti di proteine gef e plasmidi idonei per la loro sintesi
US20040213789A1 (en) * 1997-09-02 2004-10-28 Oron Yacoby-Zeevi Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
US6177545B1 (en) * 1997-09-02 2001-01-23 Insight Strategy & Marketing Ltd. Heparanase specific molecular probes and their use in research and medical applications
US20010006630A1 (en) * 1997-09-02 2001-07-05 Oron Yacoby-Zeevi Introducing a biological material into a patient
US6699672B1 (en) 1997-09-02 2004-03-02 Insight Biopharmaceuticals Ltd. Heparanase specific molecular probes and their use research and medical applications
US20020088019A1 (en) * 1997-09-02 2002-07-04 Oron Yacoby-Zeevi Methods of and pharmaceutical compositions for improving implantation of embryos
US20030217375A1 (en) * 1998-08-31 2003-11-20 Eyal Zcharia Transgenic animals expressing heparanase and uses thereof
IT1306190B1 (it) * 1999-01-04 2001-05-30 Dipartimento Di Biotecnologie Mutanti di proteine e plasmidi idonei per la loro sintesi.
EP1157118A4 (en) * 1999-03-01 2002-07-17 Insight Strategy & Marketing POLYNUCLEOTID ENCODING A POLYPEPTIDE WITH HEPARANASE ACTIVITY AND ITS EXPRESSION IN GENETICALLY MODIFIED CELLS
CA2407937A1 (en) * 2000-05-05 2001-11-15 Merck Patent Gesellschaft Mit Beschraenkter Haftung New ras guanine-nucleotide-exchange factor 1 (nrg1)
FR2812945B1 (fr) * 2000-08-10 2002-10-04 Aventis Pharma Sa Utilisation de la proteine grf1 et cellules exprimant la proteine grf1 pour le criblage de molecules
US7122345B2 (en) 2001-01-09 2006-10-17 Curagen Corporation Nucleic acid encoding a NOVX13 polypeptide
US6671189B2 (en) * 2001-11-09 2003-12-30 Minebea Co., Ltd. Power converter having primary and secondary side switches
US7291725B2 (en) 2002-06-26 2007-11-06 Chiron Corporation Sos1 inhibitors
WO2004064479A2 (en) * 2003-01-17 2004-08-05 Children's Medical Center Corporation Neuroprotective therapeutics and assays for identifying the same
US20060269552A1 (en) * 2003-06-09 2006-11-30 Oron Yacoby-Zeevi Heparanase activity neutralizing anti-heparanase monclonal antibody and other anti-heparanase antibodies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0491828B1 (en) * 1989-08-21 1999-06-16 Chiron Corporation PEPTIDES FROM GTPase-ACTIVATING PROTEIN (GAP), DIAGNOSTIC AND THERAPEUTIC USE THEREOF

Also Published As

Publication number Publication date
JP3681384B2 (ja) 2005-08-10
PT637334E (pt) 2007-09-07
JPH07505774A (ja) 1995-06-29
CA2131166A1 (fr) 1993-10-28
ATE364079T1 (de) 2007-06-15
DE69334146T2 (de) 2008-01-31
FR2690162B1 (fr) 1995-08-04
EP0637334B1 (fr) 2007-06-06
FR2690162A1 (fr) 1993-10-22
EP0637334A1 (fr) 1995-02-08
WO1993021314A1 (fr) 1993-10-28
US5656595A (en) 1997-08-12
DE69334146D1 (de) 2007-07-19
ES2287927T3 (es) 2007-12-16

Similar Documents

Publication Publication Date Title
DK0637334T3 (da) Peptider med en GDP-udskiftningsfaktoraktivitet, nukleinsyresekvenser, der koder for disse peptider, fremstilling og anvendelse
DE69326250D1 (de) Neuropeptide y antagoniste
FI940027A (fi) Parannuksia itse varjoaineisiin tai parannuksia, jotka liittyvät niihin
DE69326776D1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
NO933455D0 (no) Bis-naftalimider som inneholder aminosyreavledete linkere, for anvendelse som antikreftmidler
NO952744D0 (no) Cytokinbegrensende midler
HK1013283A1 (en) Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system
DK0479948T3 (da) Sammensætninger og fremgangsmåder til syntese af natriuretisk protein-receptor B og anvendelsesfremgangsmåder
DE69228749D1 (de) Neuartige polypeptide und ihre verwendung
FI952094A0 (fi) Ihmisen serotoniinireseptoria (5-HT4B)koodaava DNA ja sen käyttö
NO972313L (no) Peptider som er i stand til å binde til GAP-protein-SH3-området, nukleotid-sekvenser som koder for dette samt fremstilling og bruk derav
ES2170747T3 (es) Analogos superiores de trombomodulina para uso farmaceutico.
DK0656780T3 (da) Lægemidler, der indeholder diphosphonsyrer og salte deraf.
ATE215123T1 (de) Or-1, ein wais-rezeptor der nuklearen rezeptoren familie
ATE309359T1 (de) Epil/plazentin
DE3674971D1 (en) P-acylaminobenzamide.
ES2059801T3 (es) Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas.
GB9604518D0 (en) Novel compounds